Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 2, 2026
Sale
Shares
42
Price
$203.57
Total Value
$8.55K
Shares Held After
42,720
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
50
Price
$202.54
Total Value
$10.13K
Shares Held After
42,762
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
83
Price
$201.65
Total Value
$16.74K
Shares Held After
42,812
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
41
Price
$200.40
Total Value
$8.22K
Shares Held After
42,895
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
204
Price
$199.69
Total Value
$40.74K
Shares Held After
42,936
% of Holdings
0.5%
Mar 2, 2026
Sale
Shares
47
Price
$197.14
Total Value
$9.27K
Shares Held After
43,140
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
4,314,939
Price
$7.01
Total Value
$30.25M
Shares Held After
29,209,776
% of Holdings
12.9%

uniQure N.V. (QURE)

KLEMT CHRISTIAN — Chief Financial Officer
Mar 2, 2026
Sale
Shares
12,532
Price
$9.95
Total Value
$124.69K
Shares Held After
198,981
% of Holdings
5.9%
Mar 2, 2026
Purchase
Shares
17,428
Price
$0.35
Total Value
$6.15K
Shares Held After
5,924,075
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
39,272
Price
$25.39
Total Value
$997.19K
Shares Held After
22,123
% of Holdings
64.0%
Mar 2, 2026
Sale
Shares
1,442
Price
$5.09
Total Value
$7.34K
Shares Held After
61,978
% of Holdings
2.3%
Mar 2, 2026
Sale
Shares
1,298
Price
$5.09
Total Value
$6.60K
Shares Held After
63,420
% of Holdings
2.0%
Mar 2, 2026
Sale
Shares
58
Price
$5.08
Total Value
$294.64
Shares Held After
64,718
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
198
Price
$5.08
Total Value
$1.01K
Shares Held After
64,776
% of Holdings
0.3%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Liu Joy — EVP and Chief Legal Officer
Mar 2, 2026
Sale
Shares
892
Price
$495.96
Total Value
$442.40K
Shares Held After
22,811
% of Holdings
3.8%
Mar 2, 2026
Sale
Shares
20,685,061
Price
$7.01
Total Value
$145.00M
Shares Held After
140,026,557
% of Holdings
12.9%

VERACYTE, INC. (VCYT)

Febbo Phillip G. — Chief Scientific & Med Officer
Mar 2, 2026
Sale
Shares
13,425
Price
$36.16
Total Value
$485.43K
Shares Held After
117,346
% of Holdings
10.3%

ANI PHARMACEUTICALS INC (ANIP)

Mutz Christopher — HEAD OF RARE DISEASE
Mar 2, 2026
Sale
Shares
417
Price
$74.00
Total Value
$30.86K
Shares Held After
103,508
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
10,000
Price
$25.65
Total Value
$256.52K
Shares Held After
49,744
% of Holdings
16.7%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Mar 2, 2026
Sale
Shares
9,000
Price
$29.72
Total Value
$267.49K
Shares Held After
89,389
% of Holdings
9.1%

Allogene Therapeutics, Inc. (ALLO)

Beneski Benjamin Machinas — SVP, Chief Technical Officer
Mar 2, 2026
Sale
Shares
7,132
Price
$2.60
Total Value
$18.54K
Shares Held After
203,040
% of Holdings
3.4%

Alkermes plc. (ALKS)

Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Mar 2, 2026
Sale
Shares
2,034
Price
$29.29
Total Value
$59.58K
Shares Held After
237,660
% of Holdings
0.8%

Vericel Corp (VCEL)

Halpin Michael — Chief Operating Officer
Mar 2, 2026
Sale
Shares
10,305
Price
$35.30
Total Value
$363.77K
Shares Held After
16,080
% of Holdings
39.1%
Mar 2, 2026
Sale
Shares
10,000
Price
$212.52
Total Value
$2.13M
Shares Held After
117,185
% of Holdings
7.9%
Mar 2, 2026
Sale
Shares
5,714
Price
$45.92
Total Value
$262.39K
Shares Held After
61,324
% of Holdings
8.5%
Mar 2, 2026
Sale
Shares
22,223
Price
$44.88
Total Value
$997.37K
Shares Held After
67,038
% of Holdings
24.9%
Mar 2, 2026
Sale
Shares
12,063
Price
$44.20
Total Value
$533.18K
Shares Held After
89,261
% of Holdings
11.9%

Tempus AI, Inc. (TEM)

Rogers James William — Chief Financial Officer
Mar 2, 2026
Sale
Shares
11,414
Price
$50.69
Total Value
$578.58K
Shares Held After
127,248
% of Holdings
8.2%
Shares
156,235
Price
$8.17
Total Value
$1.28M
Shares Held After
2,704,496
% of Holdings
5.5%

Vericel Corp (VCEL)

Flynn Sean C. — Chief Legal Officer
Mar 2, 2026
Sale
Shares
15,000
Price
$35.36
Total Value
$530.40K
Shares Held After
1,262
% of Holdings
92.2%

Vericel Corp (VCEL)

Flynn Sean C. — Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,421
Price
$34.75
Total Value
$223.13K
Shares Held After
1,262
% of Holdings
83.6%
Mar 2, 2026
Sale
Shares
100
Price
$10.83
Total Value
$1.08K
Shares Held After
21,906
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,911
Price
$1.43
Total Value
$4.16K
Shares Held After
365,734
% of Holdings
0.8%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
1,861
Price
$1.43
Total Value
$2.66K
Shares Held After
368,645
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,125
Price
$1.43
Total Value
$3.04K
Shares Held After
370,506
% of Holdings
0.6%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
835
Price
$1.43
Total Value
$1.19K
Shares Held After
372,631
% of Holdings
0.2%

Vanda Pharmaceuticals Inc. (VNDA)

Birznieks Gunther — SVP, Business Development
Mar 2, 2026
Sale
Shares
42,431
Price
$8.27
Total Value
$350.73K
Shares Held After
494,197
% of Holdings
7.9%
Mar 2, 2026
Sale
Shares
6,097
Price
$8.30
Total Value
$50.60K
Shares Held After
89,790
% of Holdings
6.4%
Mar 2, 2026
Sale
Shares
583
Price
$47.01
Total Value
$27.41K
Shares Held After
45,761
% of Holdings
1.3%
Mar 2, 2026
Sale
Shares
1,292
Price
$46.67
Total Value
$60.30K
Shares Held After
46,344
% of Holdings
2.7%
Mar 2, 2026
Sale
Shares
10,429
Price
$47.01
Total Value
$490.31K
Shares Held After
98,748
% of Holdings
9.6%
Mar 2, 2026
Sale
Shares
22,487
Price
$46.67
Total Value
$1.05M
Shares Held After
109,177
% of Holdings
17.1%

Oscar Health, Inc. (OSCR)

McAnaney Adam — Chief Legal Officer
Mar 2, 2026
Sale
Shares
18,710
Price
$13.39
Total Value
$250.53K
Shares Held After
227,955
% of Holdings
7.6%
Mar 2, 2026
Sale
Shares
197,855
Price
$13.29
Total Value
$2.63M
Shares Held After
1,356,646
% of Holdings
12.7%

Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,594
Price
$3.31
Total Value
$8.59K
Shares Held After
28,100
% of Holdings
8.5%

Whitehawk Therapeutics, Inc. (WHWK)

BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Mar 2, 2026
Sale
Shares
1,834
Price
$3.31
Total Value
$6.07K
Shares Held After
206,019
% of Holdings
0.9%
Mar 2, 2026
Sale
Shares
5,100
Price
$3.31
Total Value
$16.88K
Shares Held After
44,579
% of Holdings
10.3%

Alector, Inc. (ALEC)

Rosenthal Arnon — Director
Mar 2, 2026
Sale
Shares
81,864
Price
$2.12
Total Value
$173.82K
Shares Held After
2,338,176
% of Holdings
3.4%

Ultragenyx Pharmaceutical Inc. (RARE)

Horn Howard — Chief Financial Officer
Mar 2, 2026
Sale
Shares
3,119
Price
$22.54
Total Value
$70.30K
Shares Held After
86,669
% of Holdings
3.5%

Ultragenyx Pharmaceutical Inc. (RARE)

Horn Howard — Chief Financial Officer
Mar 2, 2026
Sale
Shares
5,290
Price
$22.80
Total Value
$120.61K
Shares Held After
89,788
% of Holdings
5.6%
Version: v26.3.33